Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid

MF Beal, NW Kowall, DW Ellison, MF Mazurek… - Nature, 1986 - nature.com
Huntington's disease (HD) is an autosomal dominant neurological disorder characterized
by progressive chorea, cognitive impairment and emotional disturbance 1 . The disease …

Catatonic syndrome in a general psychiatric inpatient population: frequency, clinical presentation, and response to lorazepam.

…, AM Hildebrand, BG Furlong, MF Mazurek - The Journal of clinical …, 1990 - europepmc.org
In a prospective open trial conducted on a general psychiatric ward, the authors diagnosed
catatonic syndrome 15 times in 12 patients over a 1-year period. These 12 patients …

Catatonia and its treatment

PI Rosebush, MF Mazurek - Schizophrenia bulletin, 2010 - academic.oup.com
Psychiatric diagnoses are currently categorized on a syndromic basis. The syndrome of
catatonia, however, remains in a diagnostic limbo, acknowledged predominantly as a subtype of …

[HTML][HTML] Catatonia: our current understanding of its diagnosis, treatment and pathophysiology

SA Rasmussen, MF Mazurek… - World journal of …, 2016 - ncbi.nlm.nih.gov
Catatonia is a psychomotor syndrome that has been reported to occur in more than 10% of
patients with acute psychiatric illnesses. Two subtypes of the syndrome have been identified. …

Reduced numbers of somatostatin receptors in the cerebral cortex in Alzheimer's disease

MF Beal, MF Mazurek, VT Tran, G Chattha, ED Bird… - Science, 1985 - science.org
Somatostatin receptor concentrations were measured in patients with Alzheimer's disease
and controls. In the frontal cortex (Brodmann areas 6, 9, and 10) and temporal cortex (…

Early Career Psychiatrists The Psychiatric Manifestations of Mitochondrial Disorders: A Case and Review of the Literature

…, SL Garside, MA Tarnopolsky, MF Mazurek… - J Clin …, 2012 - psychiatrist.com
Objective: Mitochondrial disorders are caused by gene mutations in mitochondrial or nuclear
DNA and affect energy-dependent organs such as the brain. Patients with psychiatric illness…

[HTML][HTML] The neuropsychiatric profile of Addison's disease: revisiting a forgotten phenomenon

…, PI Rosebush, MF Mazurek - The Journal of …, 2006 - Am Neuropsych Assoc
METHOD A patient presenting with psychotic symptoms was referred to our psychiatry service
from the emergency department. We diagnosed her with underlying Addison’s disease. …

A postmortem study of amino acid neurotransmitters in Alzheimer's disease

DW Ellison, MF Beal, MF Mazurek… - Annals of Neurology …, 1986 - Wiley Online Library
Concentrations of putative neurotransmitter amino acids were measured in postmortem brains
from 10 patients with Alzheimer's disease and 10 controls. Glutamate, aspartate, taurine, γ…

Neuropeptide Y immunoreactivity is reduced in cerebral cortex in Alzheimer's disease

MF Beal, MF Mazurek, GK Chattha… - Annals of Neurology …, 1986 - Wiley Online Library
Neuropeptide Y is a 36–amino acid peptide that is found in high concentrations in cerebral
cortex and is contained in cortical neurons. We measured concentrations of this peptide in …

The treatment of neuroleptic malignant syndrome are dantrolene and bromocriptine useful adjuncts to supportive care?

PI Rosebush, T Stewart, MF Mazurek - The British Journal of …, 1991 - cambridge.org
In a prospective study of 20 patients with NMS, those who received dantrolene (2 patients)
or bromocriptine (2 patients) or both (4 patients) tended to have a more prolonged course of …